These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2945270)

  • 41. Life-threatening sublingual hematoma in a severely hemophilic patient with factor VIII inhibitor.
    Takeuchi M; Shikimori M; Kaneda T
    J Oral Maxillofac Surg; 1986 May; 44(5):401-3. PubMed ID: 3084733
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Letter: Factor-VIII inhibitor bypassing activity.
    Pollock A; Lewis MJ
    Lancet; 1976 Jul; 2(7975):43-4. PubMed ID: 59103
    [No Abstract]   [Full Text] [Related]  

  • 43. Activated F IX concentrate (FEIBA) used in the treatment of haemophilic patients with antibody to F VIII.
    Stenbjerg S; Jørgensen J
    Acta Med Scand; 1978; 203(6):471-6. PubMed ID: 665313
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Treatment of patients with hemophilia A having antibodies to factor VIII].
    Lopaciuk S; Ziemski JM
    Acta Haematol Pol; 1979; 10(2):115-22. PubMed ID: 474044
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comprehensive management of haemophilia.
    Kasper CK; Dietrich SL
    Clin Haematol; 1985 Jun; 14(2):489-512. PubMed ID: 3930117
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Activated factor IX complex in treatment of surgical cases of hemophilia A with inhibitors.
    Hanna WT; Madigan RR; Miles MA; Lange RD
    Thromb Haemost; 1981 Oct; 46(3):638-41. PubMed ID: 6976016
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [A case of sigmoid cancer who acquired factor V inhibitor producibility and treated with factor VIII inhibitor bypassing activity preparation FEIBA--with bibliographic review (author's transl)].
    Abe T; Kazama M; Itokazu K; Kinoshita T; Ogushi T; Tahara C; Fukui H
    Rinsho Ketsueki; 1980 Nov; 21(11):1664-73. PubMed ID: 6782277
    [No Abstract]   [Full Text] [Related]  

  • 48. Management of Ludwig's angina in a patient with severe hemophilia A with factor VIII inhibitors: report of case.
    Nelson L; Elfman J; Cohen A
    ASDC J Dent Child; 1985; 52(4):306-11. PubMed ID: 3160733
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Disseminated intravascular coagulation after infusion of FEIBA (factor VIII inhibitor bypassing activity) in a patient with acquired haemophilia.
    Rodeghiero F; Castronovo S; Dini E
    Thromb Haemost; 1982 Dec; 48(3):339-40. PubMed ID: 6984544
    [No Abstract]   [Full Text] [Related]  

  • 50. Conjectures on factor VIII bypassing activity.
    Aronson DL
    Prog Clin Biol Res; 1981; 72():103-21. PubMed ID: 6977778
    [No Abstract]   [Full Text] [Related]  

  • 51. DDAVP and EACA used for minor oral surgery in von Willebrand disease.
    Williamson R; Eggleston DJ
    Aust Dent J; 1988 Feb; 33(1):32-6. PubMed ID: 2970252
    [No Abstract]   [Full Text] [Related]  

  • 52. Prostatectomy in haemophilia and Christmas disease.
    Kernoff PB
    Br J Urol; 1972 Feb; 44(1):51-7. PubMed ID: 4113852
    [No Abstract]   [Full Text] [Related]  

  • 53. Haemophilia part 1: an introduction.
    Khair K
    Br J Nurs; 2013 Jun 13-26; 22(11):620. PubMed ID: 23899729
    [No Abstract]   [Full Text] [Related]  

  • 54. The optimal treatment for haemophiliacs who have developed factor VIII or -IX antibodies.
    Engelfriet CP; Reesink HW; Mannucci PM; Gringeri A; Ingerslev J; Brettler DB; Mauser-Bunschoten EP; Negrier C; Berntorp E; Smith OP; Shapiro AD
    Vox Sang; 2000; 78(4):256-61. PubMed ID: 10970234
    [No Abstract]   [Full Text] [Related]  

  • 55. Incidence of immune responses following 102 infusions of autoplex in 18 hemophilic patients with antibody to factor VIII.
    Laurian Y; Girma JP; Lambert T; Meyer D; Larrieu MJ
    Blood; 1984 Feb; 63(2):457-62. PubMed ID: 6419798
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Bilateral prosthesis of the knee in a hemophilia A patient with an inhibitor].
    Lauroua P; Barbier F; Dieu P; Dumora D; Moulinier J
    Ann Fr Anesth Reanim; 1986; 5(2):154-6. PubMed ID: 3089078
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Non-activated and activated prothrombin complex concentrates, Proplex and Feiba, in the treatment of a hemophilia B patient with high titer inhibitor against factor IX].
    Niiya K; Hirose S; Taguchi H; Miyoshi I
    Rinsho Ketsueki; 1985 Jun; 26(6):980-4. PubMed ID: 3877825
    [No Abstract]   [Full Text] [Related]  

  • 58. HAEMATURIA IN A HAEMOPHILIAC TREATED WITH E-AMINOCAPROIC ACID.
    BARKHAN P
    Lancet; 1964 Nov; 2(7368):1061. PubMed ID: 14206025
    [No Abstract]   [Full Text] [Related]  

  • 59. Desmopressin acetate prophylaxis in a patient with hemophilia A: report of case.
    Herrin RA; Boyd JF
    J Am Dent Assoc; 1988 Oct; 117(5):593-4. PubMed ID: 2976070
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multicenter retrospective study on the utilization of FEIBA in France in patients with factor VIII and factor IX inhibitors. French FEIBA Study Group. Factor Eight Bypassing Activity.
    Negrier C; Goudemand J; Sultan Y; Bertrand M; Rothschild C; Lauroua P
    Thromb Haemost; 1997 Jun; 77(6):1113-9. PubMed ID: 9241742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.